Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Foltene (often marketed as Foltène Pharma) is a line of hair and scalp care products developed by Gerolymatos International. The products are primarily indicated for the treatment of hair loss (alopecia) and thinning hair in both men and women. The core active ingredients in Foltene formulations include Tricosaccaride and Tricalgoxyl, which are proprietary mixtures of natural mucopolysaccharides and seaweed-derived sulfated oligosaccharides. These components are designed to stimulate hair growth, strengthen the hair shaft, and normalize the life cycle of the hair by extending the anagen phase. As a consumer healthcare and over-the-counter (OTC) brand, Foltene is marketed globally for hair rejuvenation and scalp health, bridging the gap between cosmetic hair care and therapeutic dermatological treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Foltene.